Thermo Fisher News
-
The $14.5 billion investment by the U.S. in the Human Genome Project, completed a decade ago, has paid off more than 60-fold in new jobs, drugs and a rapidly expanding genetics industry, an analysis has found.
-
Sometimes deals that never happen are the best kind -- at least for Goldman Sachs Group Inc.
-
Thermo Fisher Scientific Inc. was accused by the buyers of its laboratory furniture factory in Reynosa, Mexico, of failing to disclose that the plant was “under siege” by the Gulf Cartel.
-
A Life Technologies Corp. shareholder sued to block the $13.6 billion acquisition of the biotechnology equipment maker by Thermo Fisher Scientific Inc., saying the offer is unfair to investors.
-
On a conference call with investors last month, billionaire John Paulson boasted that one of his biggest hedge funds would have been up 15 percent this year -- if only he hadn’t owned gold stocks.
-
Sigma-Aldrich Corp. went toe-to-toe against larger rival Thermo Fisher Scientific Inc. to acquire Life Technologies Corp., said people with knowledge of the matter, bidding through the weekend before falling short against Thermo’s $13.6 billion offer.
-
John Paulson, the billionaire hedge- fund manager battered by the selloff in gold, pared stakes in gold miners last quarter while adding shares of companies that stand to benefit from a stronger economy.
-
Thermo Fisher Scientific Inc., the second-biggest maker of life-sciences equipment by market value, agreed to buy Life Technologies Corp. for $13.6 billion in cash in a deal that expands its reach in medical testing.
-
Thermo Fisher Scientific Inc. is in exclusive talks to buy Life Technologies Corp. for more than $70 a share, according to people familiar with the discussions.
-
Thermo Fisher Scientific Inc. is the leading bidder for Life Technologies Corp., having won exclusive negotiating rights over the weekend with a bid for more than $75 a share, said two people familiar with the matter.
|
|
Most Popular on Bloomberg
|
| |
Rate this Page